help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-0589
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pidoux, G.
Right arrow Articles by Frendo, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pidoux, G.
Right arrow Articles by Frendo, J.-L.
Endocrinology Vol. 148, No. 11 5403-5413
Copyright © 2007 by The Endocrine Society

Human Placental Development Is Impaired by Abnormal Human Chorionic Gonadotropin Signaling in Trisomy 21 Pregnancies

Guillaume Pidoux1, Pascale Gerbaud1, Olivier Marpeau, Jean Guibourdenche, Fatima Ferreira, Josette Badet, Danièle Evain-Brion and Jean-Louis Frendo

Institut National de la Santé et de la Recherche Médicale (G.P., P.G., O.M., J.G., F.F., J.B., D.E.-B., J.-L.F.), Unité 767, Faculté des Sciences Pharmaceutiques et Biologiques (G.P., P.G., O.M., F.F., J.B., D.E.-B., J.-L.F.), and Centre National de la Recherche Scientifique (J.-L.F.), Université Paris Descartes, Paris F-75006, France; and Assistance Publique-Hôpitaux de Paris (J.G.), Hôpital Cochin, Service de Biochimie Hormonale, Paris F-75014, France

Address all correspondence and requests for reprints to: Dr. Jean-Louis Frendo, Institut National de la Santé et de la Recherche Médicale, Unité 767, Faculté de Pharmacie, 4 Avenue de l’Observatoire, 75270 Paris, France. E-mail: jean-louis.frendo{at}univ-paris5.fr.

Placental development is markedly abnormal in women bearing a fetus with trisomy 21, with defective syncytiotrophoblast (ST) formation and function. The ST occurs from cytotrophoblast (CT) fusion and plays an essential role by secreting human chorionic gonadotropin (hCG), which is essential to placental development. In trisomy of chromosome 21 (T21) pregnancies, CTs do not fuse and differentiate properly into STs, leading to the secretion of an abnormal and weakly bioactive hCG. In this study we report for the first time, a marked decrease in the number of mature hCG receptor (LH/CG-R) molecules expressed at the surface of T21-affected CTs. The LH/CG-R seems to be functional based on sequencing that revealed no mutations or deletions and binding of recombinant hCG as well as endogenous hCG. We hypothesize that weakly bioactive hCG and lower LH/CG-R expression may be involved in the defect of ST formation. Interestingly, the defective ST formation is mimicked in normal CT cultures by using LH/CG-R small interfering RNA, which result in a lower hCG secretion. Furthermore, treatment of T21-affected CTs with recombinant hCG overcomes in vitro the T21 phenotype, allowing CTs to fuse and form a large ST. These results illustrate for the first time in trisomy 21 pathology, how abnormal endogenous hCG signaling impairs human placental development.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S.F. de Medeiros and R.J. Norman
Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights
Hum. Reprod. Update, January 1, 2009; 15(1): 69 - 95.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society